Mwanzo532531 • BOM
add
Strides Pharma Science Ltd
Bei iliyotangulia
₹ 1,642.00
Bei za siku
₹ 1,595.10 - ₹ 1,652.55
Bei za mwaka
₹ 467.40 - ₹ 1,675.25
Thamani ya kampuni katika soko
149.79B INR
Wastani wa hisa zilizouzwa
elfu 35.70
Uwiano wa bei na mapato
3,338.29
Mgao wa faida
0.15%
Ubadilishanaji wa msingi
NSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(INR) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 10.88B | 16.94% |
Matumizi ya uendeshaji wa biashara | 4.99B | 13.84% |
Mapato halisi | 702.02M | 1,086.95% |
Kiwango cha faida halisi | 6.46 | 950.00% |
Mapato kwa kila hisa | — | — |
EBITDA | 2.24B | 33.22% |
Asilimia ya kodi ya mapato | 19.80% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(INR) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.97B | -19.05% |
Jumla ya mali | — | — |
Jumla ya dhima | — | — |
Jumla ya hisa | 20.72B | — |
hisa zilizosalia | 91.89M | — |
Uwiano wa bei na thamani | 7.09 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 9.17% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(INR) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | 702.02M | 1,086.95% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore in southern India. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. Its softgel manufacturing capability consists of an annual capacity of 50,000 machine hours or about three billion softgel capsules. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. In the United States and Canadian markets, the company partners with generic companies to supply retail and hospital generics in injectable products and softgels. In European markets, it has long-term relationships for the development of projects and supply agreements with the European companies. In Australia and New Zealand, the company is engaged in manufacturing and supply of soft gels and value-added manufacturing. The company has development and supply agreements with South African companies. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Wikipedia
Ilianzishwa
1990
Makao Makuu
Tovuti
Wafanyakazi
3,065